1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-14-2-209
1972-02-01
2021-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/14/2/JV0140020209.html?itemId=/content/journal/jgv/10.1099/0022-1317-14-2-209&mimeType=html&fmt=ahah

References

  1. Cochran K. W., Maassab H. F., Tsunoda A., Berlin B. S. 1965; Studies on the antiviral activity of amantadine hydrochloride. Annals of the New York Academy of Sciences 130:432
    [Google Scholar]
  2. Coto C. E., Calello M. A., Parodi A. S. 1969; Efecto de la Amantadina HC1 sabre la infectividad del virus de Junin (F,. H,. A.) in vitro e in vivo. Revista de la Asociacion Argentina de Microbiologia 1:3
    [Google Scholar]
  3. Hoffmann C. E., Neumayer E. M., Haff R. F., Goldsby R. A. 1965; Mode of action of the antiviral activity of amantadine in tissue culture. Journal of Bacteriology 90:623
    [Google Scholar]
  4. Kato N., Eggers H. J. 1969; Inhibition of uncoating of Fowl Plague Virus by i-Adamantanamine hydrochloride. Virology 37:632
    [Google Scholar]
  5. Maassab H. F., Cochran K. W. 1964; Rubella Virus: Inhibition in vitro by amantadine hydrochloride. Science, New York 145:1443
    [Google Scholar]
  6. Murphy F. A., Webb P. A., Johnson K. A., Whitfield S. G., Chappell W. A. 1970; Arenoviruses in Vero cells: Ultrastructural studies. Journal of Virology 6:507
    [Google Scholar]
  7. Pulkkinen A. J., Pfau C. J. 1970; Plaque size heterogeneity: A genetic trait of lymphocytic choriomeningitis virus. Applied Microbiology 20:123
    [Google Scholar]
  8. Rowe W. P., Murphy F. A., Bergold G. H., Casals J., Hotchin J., Johnson K. M., Lehmann-Grube F., Mims C. A., Traub E., Webb P. A. 1970a; Arenoviruses: Proposed name for a newly defined virus group. Journal of Virology 5:651
    [Google Scholar]
  9. Rowe W. P., Pugh W. E., Webb P. A., Peters C. J. 1970b; Serological relationship of the Tacaribe complex of viruses to lymphocytic choriomeningitis virus. Journal of Virology 5:289
    [Google Scholar]
  10. Schwab R. S., England A. E., Proskanzer D. C., Young R. R. 1969; Amantadine in the treatment of Parkinson’s disease. Journal of the American Medical Association 208:1168
    [Google Scholar]
  11. Togo Y., Hornick R. B., Felitti V. J., Kaufman M. L., Dawkins A. T., Kilpe V. E., Claghorn J. L. 1970; Evaluation of therapeutic efficacy of amantadine in patients with naturally occurring A 2 influenza. Journal of the American Medical Association 211:1149
    [Google Scholar]
  12. Völler G. W. 1970; Die Behandlung des Parkinson-Syndroms mit Amantadin. Deutsche Medizinische Wochenschrift 95:934
    [Google Scholar]
  13. Wallbank A. M., Matter R. E., Klinikowski N. G. 1966; I-Adamantanamine hydrochloride: Inhibition of Rous and esh sarcoma viruses in cell culture. Science, New York 152:1760
    [Google Scholar]
  14. Welsh R. M., Trowbridge R. S., Kowalski J. B., O’connell C. M., Pfau C. J. 1971; Amantadine hydrochloride inhibition of early and late stages of lymphocytic choriomeningitis virus-cell interactions. Virology 45:679
    [Google Scholar]
  15. Wildy P. 1971; Classification and nomenclature of viruses. In Monographs in Virology vol 5 (ed., J. L. Melnick) Basel: S. Karger;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-14-2-209
Loading
/content/journal/jgv/10.1099/0022-1317-14-2-209
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error